Steward Partners Investment Advisory’s Agios Pharmaceuticals AGIO Stock Holding History

Steward Partners Investment Advisory’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$334	Hold	9	–	–	﹤0.01%	4492
2026 Q1	$304	Hold	9	–	–	﹤0.01%	4295
2025 Q4	$245	Hold	9	–	–	﹤0.01%	4189
2025 Q3	$361	Hold	9	–	–	﹤0.01%	4150
2025 Q2	$299	Hold	9	–	–	﹤0.01%	4007
2025 Q1	$264	Hold	9	–	–	﹤0.01%	3906
2024 Q4	$296	Hold	9	–	–	﹤0.01%	3888
2024 Q3	$400	Hold	9	–	–	﹤0.01%	3621
2024 Q2	$388	Hold	9	–	–	﹤0.01%	3494
2024 Q1	$263	Hold	9	–	–	﹤0.01%	3461
2023 Q4	$200	Hold	9	–	–	﹤0.01%	3412
2023 Q3	$223	Hold	9	–	–	﹤0.01%	3287
2023 Q2	$255	Hold	9	–	–	﹤0.01%	3227
2023 Q1	$207	Hold	9	–	–	﹤0.01%	3226
2022 Q4	$253	Hold	9	–	–	﹤0.01%	3248
2022 Q3	$0	Hold	9	–	–	﹤0.01%	3215
2022 Q2	$0	Hold	9	–	–	﹤0.01%	3225
2022 Q1	$0	Hold	9	–	–	﹤0.01%	3268
2021 Q4	$0	Hold	9	–	–	﹤0.01%	3171
2021 Q3	$0	Hold	9	–	–	﹤0.01%	3143
2021 Q2	$0	Hold	9	–	–	﹤0.01%	7071
2021 Q1	$465	Hold	9	–	–	﹤0.01%	3354
2020 Q4	$0	Hold	9	–	–	﹤0.01%	2861
2020 Q3	$0	Hold	9	–	–	﹤0.01%	2724
2020 Q2	$0	Hold	9	–	–	﹤0.01%	2649
2020 Q1	$0	Sell	9 -900	-99%	-$41.6K	﹤0.01%	2475
2019 Q4	$43K	Sell	909 -200	-18%	-$7.56K	﹤0.01%	1464
2019 Q3	$35K	Buy	1,109 +900	+431%	+$37.3K	﹤0.01%	1503
2019 Q2	$10K	Buy	+209	New	+$11.2K	﹤0.01%	1964
2018 Q4	–	Sell	-9	Closed	-$1K	–	803
2018 Q3	$1K	Hold	9	–	–	﹤0.01%	2464
2018 Q2	$1K	Buy	+9	New	+$785	﹤0.01%	2312

Other funds holding AGIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Steward Partners Investment Advisory's AGIO Position: Q2 2026 in Review

Steward Partners Investment Advisory held its Agios Pharmaceuticals (AGIO) position steady in Q2 2026 at 9 shares worth $334. The position accounts for ﹤0.01% of the portfolio, ranked #4492.

Steward Partners Investment Advisory first reported a position in AGIO in Q2 2018 and has held it in 31 quarters since. The position peaked at $43K in Q4 2019. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

Steward Partners Investment Advisory held 9 shares of Agios Pharmaceuticals worth $334 as of Q2 2026.
Steward Partners Investment Advisory left its Agios Pharmaceuticals share count unchanged in Q2 2026.
Agios Pharmaceuticals made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #4492 holding.
Steward Partners Investment Advisory first reported a position in Agios Pharmaceuticals in Q2 2018 and has held it in 31 quarters since.
Steward Partners Investment Advisory's Agios Pharmaceuticals position peaked at $43K in Q4 2019.
238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.